The company has successfully completed Phase 2 clinical trials for its lead product candidate and is currently preparing for Phase 3 trials.
Founders
Dr. Steven A. Nissen, Dr. John D. McKinley
Company Description
Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular and metabolic diseases. The company is leveraging its proprietary technology platform to create innovative treatments that address significant unmet medical needs.